Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (20655)	5/13/1998 9:03:00 AM
From: Skeeter Bug	Read Replies (1) \| Respond to of 32384

hn, did h&q change their eps estimate for lgnd from $0.84 to $0.11? frankly, i'd be loving $0.11 and profitability :-)

To: Henry Niman who wrote (20655)	5/13/1998 9:12:00 AM
From: Mudcat	Read Replies (2) \| Respond to of 32384

Henry: the SRGN acquisition was supposed to make earnings better in 1999 not worse. If this is the case, I would prefer the .84 earnings and forget the SGRN acquisition.